New Datamonitor study at reports-research.com: Huntington’s disease: the lucrative untapped market

Posted in Pharmaceuticals / Health by admin on the January 18th, 2008 | 589 viewer

Given the relatively small number of patients with Huntington’s disease, a neurodegenerative genetic disorder, interest in this field from leading pharma players has been limited. However, with a genetic test available for this disorder, a shift in thinking towards niche conditions, and developments in the understanding of the disease, Huntington’s has the potential to become a lucrative market.

(more…)

0 Comments